SCHEMBL8069269

SCHEMBL8069269

O=C(OCc1ccccn1)c1cc[c]cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.51
RAB9A P51151 5/20 0.51
SMN1; SMN2 Q16637 5/20 0.51
LMNA P02545 2/20 0.51
PARP10 Q53GL7 1/20 0.48
CNR2 P34972 1/20 0.46
MAPT P10636 3/20 0.45
HPGD P15428 2/20 0.45
CASP3 P42574 2/20 0.45
SENP8 Q96LD8 2/20 0.45
SENP7 Q9BQF6 2/20 0.45
SENP6 Q9GZR1 2/20 0.45
MAPK1 P28482 2/20 0.45
ALDH1A1 P00352 2/20 0.45
CYP1A2 P05177 2/20 0.45
CYP2C19 P33261 2/20 0.45
TSHR P16473 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27817990 0.87 NPC1 (0.60) NPC1RAB9ASMN1; SMN2LMNAPARP10
SCHEMBL30620627 0.87 NPC1 (0.60) NPC1RAB9ASMN1; SMN2LMNAPARP10
SCHEMBL27925524 0.84 L3MBTL1 (0.54) NPC1RAB9ASMN1; SMN2LMNAPARP10
SCHEMBL11527522 0.82 NPC1 (0.64) NPC1RAB9ASMN1; SMN2LMNAPARP10
Iodomethane SCHEMBL11478139 0.78 RAB9A (0.57) NPC1RAB9ASMN1; SMN2LMNAPARP10
SCHEMBL20918141 0.78 NPSR1 (0.58) NPC1RAB9ASMN1; SMN2LMNAMAPT
SCHEMBL11529772 0.77 KMT2A (0.58) NPC1RAB9ASMN1; SMN2LMNAMAPT
Iodomethane SCHEMBL11489847 0.77 KMT2A (0.59) NPC1RAB9ASMN1; SMN2PARP10HPGD
SCHEMBL20509994 0.77 SMN1; SMN2 (0.63) NPC1RAB9ASMN1; SMN2LMNAPARP10
SCHEMBL909623 0.76 TDP1 (0.76) NPC1RAB9ASMN1; SMN2LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6071895-A RETROVIRAL PROTEASES INHIBITOR; USEFUL FOR TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS VIRAL INFECTIONS SUCH AS ACQUIRED IMMUNODEFICIENCY SYNDROME(AIDS); COMPOUND CONTAINING A CYCLIC DIAZAALKANE GROUP NARHEX LIMITED (HK) 2000-06-06 US disclosed
US-5888992-A PROTEASE INHIBITOR; VIRICIDE NARHEX LIMITED (HK) 1999-03-30 US disclosed
EP-0717736-A4 POLAR-SUBSTITUTED HYDROCARBONS NARHEX LTD (HK) 1996-08-28 EP disclosed
EP-0717736-A1 POLAR-SUBSTITUTED HYDROCARBONS NARHEX LIMITED (HK) 1996-06-26 EP disclosed
WO-1995007269-A1 POLAR-SUBSTITUTED HYDROCARBONS NARHEX LIMITED (HK) 1995-03-16 WO disclosed